The University of Chicago Header Logo

Connection

Walter M. Stadler to Biological Availability

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Biological Availability.
Walter M. Stadler
Connection Strength
0.014
Biological Availability
  1. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. J Clin Oncol. 2004 Mar 01; 22(5):909-18.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.